Chesapeake Asset Management LLC Sells 4,864 Shares of Aflac Incorporated $AFL

Chesapeake Asset Management LLC trimmed its stake in Aflac Incorporated (NYSE:AFL) by 17.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 23,493 shares of the financial services provider’s stock after selling 4,864 shares during the period. Aflac accounts for about 2.3% of Chesapeake Asset Management LLC’s investment portfolio, making the stock its 7th largest position. Chesapeake Asset Management LLC’s holdings in Aflac were worth $2,624,000 as of its most recent filing with the SEC.

A number of other large investors have also recently added to or reduced their stakes in AFL. Brighton Jones LLC lifted its stake in shares of Aflac by 64.4% in the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 5,708 shares during the last quarter. Bison Wealth LLC raised its holdings in Aflac by 4.3% in the 4th quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider’s stock worth $455,000 after acquiring an additional 183 shares during the period. Jump Financial LLC lifted its position in Aflac by 167.7% during the 1st quarter. Jump Financial LLC now owns 6,300 shares of the financial services provider’s stock worth $700,000 after acquiring an additional 3,947 shares during the last quarter. Canada Pension Plan Investment Board boosted its holdings in Aflac by 44.6% during the first quarter. Canada Pension Plan Investment Board now owns 438,668 shares of the financial services provider’s stock valued at $48,775,000 after acquiring an additional 135,214 shares during the period. Finally, Vident Advisory LLC grew its position in shares of Aflac by 47.6% in the first quarter. Vident Advisory LLC now owns 22,291 shares of the financial services provider’s stock valued at $2,479,000 after purchasing an additional 7,188 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Insider Buying and Selling at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 15,862 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $112.00, for a total transaction of $1,776,544.00. Following the completion of the transaction, the executive vice president owned 230,688 shares in the company, valued at $25,837,056. This trade represents a 6.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Steven Kent Beaver sold 5,492 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $109.53, for a total value of $601,538.76. Following the completion of the sale, the executive vice president owned 38,368 shares in the company, valued at approximately $4,202,447.04. This represents a 12.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 31,766 shares of company stock worth $3,549,706. 0.80% of the stock is currently owned by company insiders.

Aflac Stock Performance

AFL opened at $109.92 on Monday. The stock’s 50 day simple moving average is $109.99 and its 200-day simple moving average is $107.15. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.30. The stock has a market cap of $57.61 billion, a PE ratio of 14.35, a P/E/G ratio of 3.18 and a beta of 0.66. Aflac Incorporated has a 1 year low of $96.95 and a 1 year high of $115.83.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share for the quarter. The firm had revenue of $5.91 billion for the quarter. Aflac had a net margin of 23.55% and a return on equity of 14.97%. Sell-side analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Wednesday, February 18th will be paid a $0.61 dividend. The ex-dividend date of this dividend is Wednesday, February 18th. This is an increase from Aflac’s previous quarterly dividend of $0.58. This represents a $2.44 dividend on an annualized basis and a yield of 2.2%. Aflac’s payout ratio is presently 30.29%.

Aflac News Roundup

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Reminder of long-term shareholder returns — a retrospective piece notes that a five‑year investment in Aflac would have returned roughly 182%, reinforcing the stock’s historical resilience and dividend appeal. Article Title
• Neutral Sentiment: Industry context — a video/article explains why cancer insurance penetration is much higher in Japan than the U.S., underlining Aflac’s strategic strength in the Japanese supplemental-insurance market but not directly tied to the breach. Article Title
• Neutral Sentiment: Local news mention — a regional story about Columbus police on Christmas has no material impact on Aflac’s operations or stock. Article Title
• Negative Sentiment: Company update: Aflac says data for roughly 22.65 million people may have been exposed in the June security incident — raises concerns about regulatory investigations, breach-notification costs, credit monitoring and potential lawsuits. Article Title
• Negative Sentiment: Expanded disclosure: Multiple outlets report Aflac has disclosed the extent of the breach as more than 22 million customers impacted, with personal and health-related information involved — heightening reputational and remediation risk. Article Title
• Negative Sentiment: Broad coverage: Tech and business outlets report that the breach exposed personal and health data for over 22M people, emphasizing potential regulatory scrutiny and class-action risk. Article Title
• Negative Sentiment: Company and media follow-ups: Several updates and video segments rehash the June breach and Aflac’s statements to affected customers, keeping the issue in the news cycle and likely contributing to near‑term selling pressure. Article Title
• Negative Sentiment: Video coverage: News videos and recaps (Yahoo/MSN) summarize the breach timeline and the company’s recent disclosures, prolonging investor focus on remediation costs and liability exposure. Article Title

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on AFL. Cowen reissued a “hold” rating on shares of Aflac in a research report on Monday, December 22nd. Piper Sandler set a $125.00 price target on Aflac and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Wells Fargo & Company increased their price objective on Aflac from $107.00 to $109.00 and gave the company an “equal weight” rating in a research report on Friday, November 7th. TD Cowen raised their price objective on shares of Aflac from $100.00 to $102.00 and gave the stock a “hold” rating in a research note on Monday, December 22nd. Finally, JPMorgan Chase & Co. upped their target price on shares of Aflac from $100.00 to $101.00 and gave the company a “neutral” rating in a research note on Wednesday, November 5th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $109.83.

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.